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The tachykinin hemokinin-1 (HK-1) is involved in immune cell development and
inflammation, but little is known about its function in pain. It acts through the NK1
tachykinin receptor, but several effects are mediated by a yet unidentified target.
Therefore, we investigated the role and mechanism of action of HK-1 in arthritis
models of distinct mechanisms with special emphasis on pain. Arthritis was induced
by i.p. K/BxN serum (passive transfer of inflammatory cytokines, autoantibodies), intra-
articular mast cell tryptase or Complete Freund’s Adjuvant (CFA, active immunization) in
wild type, HK-1- and NK1-deficient mice. Mechanical- and heat hyperalgesia determined
by dynamic plantar esthesiometry and increasing temperature hot plate, respectively,
swelling measured by plethysmometry or micrometry were significantly reduced in HK-1-
deleted, but not NK1-deficient mice in all models. K/BxN serum-induced histopathological
changes (day 14) were also decreased, but early myeloperoxidase activity detected by
luminescent in vivo imaging increased in HK-1-deleted mice similarly to the CFA model.
However, vasodilation and plasma protein extravasation determined by laser Speckle and
fluorescent imaging, respectively, were not altered by HK-1 deficiency in anymodels. HK-1
induced Ca2+-influx in primary sensory neurons, which was also seen in NK1-deficient cells
and after pertussis toxin-pretreatment, but not in extracellular Ca2+-free medium. These
are the first results showing that HK-1 mediates arthritic pain and cellular, but not vascular
inflammatory mechanisms, independently of NK1 activation. HK-1 activates primary
sensory neurons presumably via Ca2+ channel-linked receptor. Identifying its target
opens new directions to understand joint pain leading to novel therapeutic opportunities.
Keywords: experimental arthritis, arthritic pain, primary sensory neuron, neuroinflammation, tachykinin, in vivo
optical imaging
INTRODUCTION
Rheumatoid arthritis (RA) is the most common autoimmune disorder of the joints characterized by
chronic inflammation and severe pain. Although the inflammation can be effectively controlled by
nonsteroidal anti-inflammatory drugs (NSAIDs), steroids, disease-modifying antirheumatic
drugs (DMARDs) and biologic agents (Sparks, 2019), pain is often resistant to these drugs
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(McWilliams andWalsh, 2019). Persistent pain has resulted in an
increased use of opioids among RA patients (Day and Curtis,
2019), though opioids are not effective in all cases (Chancay et al.,
2019) suggesting more complex pain pathomechanisms in RA
and making pain management an unmet medical need.
The joints are densely innervated by capsaicin-sensitive
peptidergic sensory nerves (Donaldson et al., 1995) expressing,
among others, the transient receptor potential vanilloid 1
(TRPV1) and ankyrin 1 (TRPA1) ion channels activated by a
broad range of inflammatory mediators (Pinho-Ribeiro et al.,
2017). These nerves play an important role in complex neuro-
vascular-immune interactions resulting in chronic pain (Sun and
Dai, 2018). Recently, intensive investigations have been initiated
to reveal sensitization processes at molecular (Sommer and Kress,
2004) and histological levels alike (Ebbinghaus et al., 2019) that
convert inflammatory to neuropathic pain and contribute to
persistent arthritic pain. Exploration of its pathophysiological
processes is hindered by the fact that no single animal model can
mimic every aspect of RA, conclusions drawn using different
models might not necessarily apply to the human disease (Krock
et al., 2018). Studying the role of endogenous molecules of the
sensory-vascular-immune interactions is essential to identify key
mediators and potential novel drug targets.
Tachykinins are a family of neuropeptides that have been
shown to play important roles in immune mechanisms,
inflammatory vascular changes and pain (Onaga, 2014).
Their best-known member, substance p (SP) acts mainly
through the tachykinin neurokinin-1 receptor (NK1R), but
can also bind to the other two tachykinin receptors, NK2R
and NK3R, with much lower affinities. NK1R plays a key role in
the wind-up mechanism in the spinal dorsal horn (Herrero
et al., 2000), which is a crucial element in central sensitization
leading to chronic pain. SP through NK1R also sensitizes the
peripheral terminals of nociceptors (Nakamura-Craig and
Smith, 1989). NK1R antagonists were developed as analgesic
drug candidates, but despite promising preclinical results, they
did not prove to be effective in human pain conditions.
Therefore, tachykinins fell outside the focus of pain research
until the discovery of hemokinin-1 (HK-1) in 2000 (Zhang et al.,
2000) beginning a new era in this field. HK-1, encoded by the
preprotachykinin-4 gene (Tac4), was first isolated from bone
marrow B-cells (Zhang et al., 2000), and plays a role in
T-lymphopoesis as well (Zhang and Paige, 2003). HK-1
consists of 11 amino acids, it has a close structural
resemblance to SP, with seven matching aminoacids. HK-1
has the highest affinity to the NK1R similarly to SP (Morteau
et al., 2001), but it has been proven that HK-1 can exert effects
through other, so far unidentified target(s) (Borbély and Helyes,
2017). Our research group was the first to describe the mediator
role of HK-1 in the chronic adjuvant-induced mouse model of
inflammation and related nociception (Borbély et al., 2013).
Recently, we proved that HK-1 is involved not only in
inflammatory, but also nerve ligation-induced neuropathic
pain, which develops independently of inflammation with
prominent central sensitization mechanisms (Hunyady et al.,
2019). The present work focused on investigating the
involvement of HK-1 in arthritis models of distinct
mechanisms with special emphasis on pain, nociceptive
sensory neurons and the molecular mechanism of action.
MATERIALS AND METHODS
Animals and Ethics
Experiments were performed on inbred 12–18-week-old
(25–30 g) male Tac4 gene-deficient (Tac4−/−) knockout (KO)
and NK1 receptor-deleted (Tacr1−/−) mice and their C57BL/6J
wild type controls (WT) purchased from Charles-River Ltd.
(Hungary). The original Tacr1−/− breeding pairs (De Felipe
et al., 1998) were obtained from the University of Liverpool,
United Kingdom, The Tac4−/− strain was donated by A. Berger
(Berger et al., 2010). Both KO strains were generated on C57BL/6J
background and backcrossed to homozygosity for over five
generations. The mutated allele’s germline transmission and
excision of the selection cassette were verified by PCR analysis.
The experimenters were blinded from the genotype and
treatments in all cases. Animals were bred and kept in the
conventional Laboratory Animal House of the Department of
Pharmacology and Pharmacotherapy, University of Pécs at
24–25°C, 12 h light/dark cycles on wood shaving bedding in a
standard polycarbonate cage with two to six mice per cage and
provided with standard rodent diet and water ad libitum.
All experiments were carried out according to the European
Communities Council Directive of 2010/63/EU, Consideration
Decree of Scientific Procedures of Animal Experiments (243/
1988) and Ethical Codex of Animal Experiments and to the NIH
guidelines (Guide for the Care and Use of Laboratory Animals,
NIH Publication 86–23). The project was approved by the Ethics
Committee on Animal Research of the University of Pécs and
license was provided (BA 02/2000–2/2012).
Serum Transfer Arthritis
K/BxN arthritogenic and BxN non-arthritogenic sera were
harvested as described earlier (Jakus et al., 2010). Arthritis
was induced by intraperitoneally (i.p.) injecting 150–150 μL
of the arthritogenic serum on the 0 and 3 day of the
experiment. The control groups received the same amount of
non-arthritogenic serum. The mechanonociceptive threshold,
heat threshold and cold tolerance were measured (methods
described below). Paw edema was quantified using
plethysmometry (Ugo Basile 7140), bodyweight was
monitored after the first serum administration as a parameter
of general well-being. Weight loss was given as the percentage of
lost weight compared to pretreatment control values. Arthritis
severity was scored using a semiquantitative visual scale where
0–0.5 was no change and 10 was maximal inflammation (Jakus
et al., 2010). Swelling and redness of all four feet were
considered for the score. To assess joint function mice were
placed on a horizontal grid, the grid was turned upside-down
and the latency to fall was measured. The grasping ability
needed in this test correlates with the joint function. In vivo
imaging was performed with IVIS Lumina II (PerkinElmer; 60 s
acquisition, F/Stop  1, Binning  8) before treatment and 2 and
6 days after to quantify plasma extravasation and
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myeloperoxidase (MPO) activity, as described below. We chose
these time points to collect data from the acute phase on day 2
when the vascular inflammatory components are predominant,
and from the chronic phase on day 6, when the cellular
inflammatory mechanisms are more remarkable (Horváth
et al., 2016). On the 14th day after serum administration
tibiotarsal joints were removed for histological staining with
Safranin stain. Fibroblast proliferation, leukocyte invasion and
thickness of synovium were evaluated with 0–3 score depending
on severity, the maximum possible score being 9.
Mast Cell Tryptase (MCT)-Induced Acute
Knee Monoarthritis
MCT can be found in abundance in synovial fluid contributing
to the inflammation in different types of arthritis (RA,
osteoarthritis, spondyloarthritis) by activating the protease-
activated receptor 2 (PAR2) on the sensory nerves and
inflammatory cells. To investigate acute inflammatory
synovial microcirculatory changes, 1 h after guanethidine
(12 mg/kg i. p., Sigma) pretreatment, MCT (Merck Millipore)
was applied topically to the synovial membrane of the knee joint
(12 μg/ml, 20 μL), after removing the skin under ketamine- and
xylazine-induced (100 mg/kg and 10 mg/kg i. p, respectively)
anesthesia. Contralateral knee joint was treated with 0.9% saline.
Blood flow was continuously monitored by laser Speckle
imaging for 40 min after the treatment, and the differences
compared to the baseline values of the respective area were
calculated. To measure acute inflammatory hyperalgesia and
edema, MCT was injected intra-articularly (20 μL, 12 μg/ml)
into the right knee joint. The paw mechanonociceptive
threshold and knee diameter were measured at 2, 4, and 6 h
post-injection.
Complete Freund’s Adjuvant (CFA)-Induced
Subacute Knee Monoarthritis
CFA is heat-killed Mycobacterium tuberculosis suspended in
paraffin oil (1 mg/ml; Sigma-Aldrich) which is taken up by
macrophages, activate their reactive oxygen species, cytokine
and enzyme generation within a few hours causing localized
arthritis of the injected joint without severe systemic symptoms.
CFA (20 μL) was injected into the right mouse knee joint
under ketamin-xylazine anesthesia as described above.
Contralateral knee joint was treated with 20 μL 0.9% saline.
Paw mechanonociceptive threshold and antero-posterior knee
diameter were measured 2, 6, and 24 h after CFA administration,
changes were expressed as percentage of change compared to the
pre-injection values. MPO activity was measured 24 h after
treatment.
Measurement of the Mechanonociceptive
and Heat Thresholds
The mechanonociceptive threshold was measured with the
dynamic plantar esthesiometer (DPE; Ugo Basile 37000) before
(to determine baseline nociceptive threshold) and after treatment.
The post-treatment values are shown as the percentage of
threshold-decrease of the individual mouse compared to its
baseline thresholds. Heat threshold was determined as the
temperature where the animal showed nocifensive behavior
(shaking, licking, lifting of the hind paw) on increasing
temperature hot plate (IITC Life Sciences), the cut-off value
was set at 53 °C. Cold hyperalgesia was given as the latency to
paw-withdrawal from 0°C water.
In vivo Optical Imaging
Mice were anesthetized with ketamine-xylazine anesthesia for in
vivo imaging with IVIS Lumina II (PerkinElmer; 120s
acquisition, F/stop  1, Binning  8) instrument and Living
Image® software (PerkinElmer). Luminol sodium salt (5-amino-
2,3-dihydro-1,4-phthalazine-dione; 150 mg/kg) injection was
given i. p. in sterile PBS solution for MPO imaging. MPO
from neutrophil granulocytes produces reactive oxygen
species which interact with luminol and result in luminescent
signals which we measured 10 min after administration.
Luminescence was expressed as total radiance (total photon
flux/s) in identical Regions of Interests (ROIs) around the joints.
Inflammatory vascular leakage was evaluated by fluorescence
imaging with the Fluorescent Molecular Tomography (FMT)
2000 system (PerkinElmer Ltd.) using the 680 nm laser of the
equipment. A micellar formulation of the fluorescent IR-676 dye
(Spectrum-Info) dissolved in a 5w/v% aqueous solution of
Kolliphor HS 15 (polyethylene-glycol-15-hydroxystearate;
Sigma-Aldrich) was given i. v. in a 0.5 mg/kg dose under
ketamine-xylazine anesthesia. The measurement was carried
out 20 min afterward dye administration with fluorescence
expressed as the calculated amount of fluorophore (pmol)
(Botz et al., 2015) in identical Regions of Interests (ROIs)
around the ankle joints.
Tissue Preparation and Protocol for qPCR
L3-L5 lumbar spinal cord and the respective dorsal root ganglia
(DRG; total of six DRGs pooled per mouse) were obtained from
WT mice 6 days after treatment when behavioral results showed
the greatest difference between WT and Tac4−/− animals. Mice
were divided into three groups: K/BxN treated arthritic (n  8),
BxN serum treated control (n  5) and intact control (n  7).
Spinal cord samples of Tac4−/− mice served as negative (n  3),
while inguinal lymph nodes from WT mice served as positive
controls (n  2).
Tissue samples were harvested after cervical dislocation and
placed immediately into 500 μL TRI reagent (Molecular Research
Center, Inc.), snap-frozen on dry ice, then stored on -80°C until
processing.
Tissue samples were thawed out on ice and homogenized in
TRI reagent. After homegenization, total RNA was extracted
using Direct-zol RNA MicroPrep (Zymo Research) according
to the manufacturer’s instructions (Aczél et al., 2020). The
quantity of the extracted RNA was examined using Nanodrop
ND-1000 Spectrophotometer V3.5 (Nano-Drop Technologies,
Inc.). RNA samples were treated with dnase I in order to
remove contamining genomic DNA, and 500 ng of RNA was
reverse transcribed into cDNA using High Capacity cDNA
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Reverse Transcription Kit (Thermo Fisher Scientific).
SensiFAST™ Probe Lo-ROX Kit (Meridiane Bioscience,
Memphis, United States) was used according to the manual in
the QuantStudio five Real-Time PCR System (Thermo Fisher
Scientific). Transcripts of the reference gene glucuronidase beta
(Gusb, Kecskés et al., 2020) and the target gene Tac4 were
evaluated using FAM-conjugated specific probes
(Mm01197698_m1, and Mm00474083_m1 respectively,
Thermo Fisher Scientific). The gene expression was calculated
using ΔΔCt method (Pfaffl, 2001).
Primary Cultures of Trigeminal Ganglion
(TG) Neurons
TG cultures were prepared from neonatal NMRI mice. Ganglia
were excised in ice-cold phosphate-buffered saline (PBS),
incubated in PBS containing collagenase Type XI (1 mg/ml)
and then in PBS with deoxyribonuclease I (1,000 units/ml) for
8 min. Cells were plated on poly-D-lysin-coated glass coverslips
in a medium containing Dulbecco’s-Modified Eagle Medium-
low glucose (D-MEM), 5% horse serum, 5% newborn calf
serum, 5% fetal bovine serum, 0.1% penicillin-streptomycin,
200 ng/ml nerve growth factor (NGF). Cells were maintained at
37°C in a humidified atmosphere with 5% CO2 (Szoke et al.,
2010).
Ratiometric Technique of Intracellular Free
Calcium Concentration ([Ca2+]i)
Measurement with the Fluorescent
Indicator Fura-2 AM.
One-two-day-old neurons were incubated for 30 min at 37°C
with 1 µM of fluorescent Ca2+ indicator dye, fura-2-AM. Cells
were washed with extracellular solution (ECS). Calcium
transients were detected with microfluorimetry as described
elsewhere (Szoke et al., 2010). Fluorescent imaging was
performed with an Olympus LUMPLAN FI/x20 0.5 W water
immersion objective and a digital camera (CCD, SensiCam
PCO) and a Monochromator (Polychrome II., Till Photonics)
(generated light: 340 and 380 nm, emitted light: 510 nm). Axon
Imaging Workbench 2.1 (AIW, Axon Instruments) software
was used, R  F340/F380 was monitored, data were subsequently
processed by the Origin software version 7.0 (Originlab Corp.).
Ratiometric response peak magnitude was measured. Capsaicin
(330 nM), AITC (100 µM), HK-1 (500 nM, 1 µM) and SP
(500 nM, 1 µM) were administered during the experiments.
CP99994, AMG 9810 and HC 030031 were administered in
10 µM concentration.
Drugs and Chemicals
AITC (Sigma) was dissolved in dimethyl sulfoxide (DMSO)
(Sigma) to obtain 10 mM stock solution. Further dilutions
were made with ECS solution to reach final concentrations of
100 μM. Capsaicin (Sigma) was dissolved in DMSO to obtain
a 10 mM stock solution. Further dilutions were made with
ECS or Hank’s solution to reach final concentrations of 330
or 100 nM, respectively. Penicillin-streptomycin was
purchased from Gibco. D-MEM-low glucose, collagenase
type XI, deoxyribonuclease I, horse serum, newborn calf
serum, fetal bovine serum, poly-D-lysine, glycine, NGF,
pertussis toxin (PTX), SP, HK-1 were purchased from
Sigma. CP99994, AMG 9810 and HC 030031 were
purchased from Tocris.
Statistical Analysis
The treatments were not randomized within cages to prevent
control animals from harming the arthritic animals. Results are
expressed as the means ± SEM of n  6–10 mice per group in case
of in vivo functional tests. Data obtained in these experiments
were analyzed with repeated measures two-way ANOVA
followed by Bonferroni’s post-test with GraphPad Prism 5
software. In all cases p < 0.05 was accepted as statistically
significant.
RESULTS
HK-1 Mediates Mechanical Hyperalgesia,
Paw Edema and Decrease in Heat
Threshold in Chronic Immune Arthritis
Compared to pre-treatment control values, a significant decrease
in pain threshold developed in WT mice by the 5th day of the
experiment (-33.5 ± 4.1%). This spontaneously resolved by the
end of the 3rd week. Tac4−/− mice showed significantly milder
decrease in the pain threshold (-19.4 ± 3.8% on day 5) throughout
the entire experiment (Figure 1A). The decrease in heat threshold
began in WT mice at the 4th day (47.6 ± 1.3°C) and was
significantly less severe in Tac4−/− mice (50.6 ± 0.8°C)
(Figure 1B).
Paw edema developed by the 3rd day of the experiment
(43.8 ± 7.2% in WT), and spontaneously resolved by 2 weeks
after serum administration with significantly milder edema
seen in Tac4−/− mice (Figure 1C). Decrease in cold tolerance,
body weight and time spent on grid occurred in the
experiment, but gene deletion resulted in no difference
(Figures 1D–F). Change in mechanonociceptive threshold,
arthritis score, paw volume, cold tolerance, body weight and
time spent on grid in NK1R deficient mice showed no
difference compared to WT mice (Supplementary
Figure S1).
HK-1 Decreases MPO-Activity in K/BxN
Serum-Transfer Arthritis
Tac4−/− mice showed a marked increase in MPO-activity 2 days
after serum administration (6,16 × 105 ± 6,83 × 104 p/s),
whereas in WT mice it became significant on the 4th day
(409,917 ± 56729) (Figure 2A). An increase in plasma
extravasation was detectable in both groups on the 2nd and
6th day, but no effect of the gene-deletion could be observed
(Figure 2B). Representative pictures of MPO-activity can be
seen on Figure 2C.
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HK-1 Increases Histopathological Arthritis
Severity
On the 14th day of the experiment WT mice had a severity score
of 4.0 ± 0.5 out of a maximum of nine points, while Tac4−/− mice
had a significantly lower score of 2.5 ± 0.5 (Figure 3).
Tac4 mRNA Expression in DRG and Spinal
Cord
Tac4 mRNA showed a stable expression in the DRG throughout
the experiment, with a slight, non-significant decrease on day 6
(Supplementary Figure S3). In dorsal spinal cord samples, Tac4
specific signals were not detectable. The specificity of the reaction
was proved by using inguinal lymph nodes as positive control.
RNA samples of Tac4−/− mice served as negative controls, in
which samples we did not observe any amplification products
with the applied probes.
HK-1 Mediates Mechanical Hyperalgesia
and Knee Edema in MCT-Induced Acute
Monoarthritis
Mechanical hyperalgesia developed inWTmice 2 days after MCT
administration (-11.8 ± 4.0%), while knee edema developed on
the 4th day (13.3 ± 1.6). Both parameters were significantly less
FIGURE 1 | Change in mechanonociceptive threshold (A), heat threshold (B), paw volume (C), cold tolerance (D), body weight (E) and time spent on grid (F) in K/
BxN serum-induced arthritis of wild type (WT) and hemokinin-1-deficient (Tac4−/−) mice in comparison with BxN serum-treated non-arthritic groups (n  4–10 per group;
*p < 0.05, **p < 0.01, ***p < 0.001 vs. arthritic WT, repeated measures two-way ANOVA + Bonferroni’s post test).
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severe in Tac4−/− mice. Increase in blood flow was detectable in
the first 40 min after treatment but showed no significant
difference between the groups (Figure 4).
HK-1 Mediates Mechanical Hyperalgesia
and Knee Edema, but Decreases MPO
Activity in CFA-Induced Subacute Knee
Inflammation
Mechanical hyperalgesia and knee edema were detectable 2, 6 and
24 h after the CFA administration. Tac4−/− mice had a
significantly milder mechanical hyperalgesia at every time
point and less severe knee edema at 24 h. Tac4−/− mice
showed a significant increase in MPO-activity (457,125 ±
94397) (Figure 5). Changes in mechanonociceptive threshold
and knee volume did not show significant difference to WT mice
in NK1R deficient mice (Supplementary Figure S2).
HK-1 Directly Activates Primary
Nociceptive Sensory Neurons
First, the effects of HK-1 and SP were investigated. Both peptides
in 500 nM (Figures 6A–E) and SP in 1 µM concentration (data
not shown) had no effect on Ca2+-influx, but 1 μM HK-1 caused
remarkable Ca2+-influx (R  0.67 ± 0.07) in 26.39 ± 4.5% of the
neurons (19 out of 72). In the next step, we investigated the
mechanism of HK-1 action and the characteristics of the Ca2+-
signal. The NK1 receptor antagonist CP99994 did not influence
the HK-1 response, 20.93 ± 3.8% of the cells (9 out of 43)
responded with Ca2+-influx (R  0.62 ± 0.08). This was
FIGURE 2 | Quantitative evaluation of MPO-activity (A) and IR-676 dye extravasation (B) in K/BxN arthritogenic serum-treated wild type (WT) and hemokinin-1-
deficient (Tac4−/−) mice. Representative images of MPO-activity (C). Box plots demonstrate medians with the upper and lower quartiles and all individual data points; n 
6–12 per group; *p < 0.05 vs. WT, ##p < 0.01, ###p < 0.001 vs. control (one-way ANOVA + Bonferroni’s post test).
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similar in neurons of NK1R gene-deleted mice (21.4 ± 3.5%, nine
out of 42 responsive cells, R  0.49 ± 0.04). The G-protein-
coupled receptor (GPCR) blocker PTX influenced neither the
ratio of the responding neurons (24.49 ± 3.6%; 12 out of 49) nor
the extent of the response (R  0.74 ± 0.03) to HK-1. In order to
investigate potential HK-1-induced Ca2+-release from
intracellular stores as a consequence of PTX-insensitive GPCR
mechanism, we did measurements using Ca2+ free ECS. No Ca2+-
signal was detected in this condition indicating that HK-1 evokes
Ca2+-influx from the extracellular space. The response to HK-1
was detected in the presence of the TRPV1 antagonist AMG8910,
22.7 ± 4% of the cells (5 out of 22) responded with Ca2+-influx (R
 0.7 ± 0.28) and the TRPA1 antagonist HC 030031, 19.2 ± 4.7%
of the cells (5 out of 26) responded with Ca2+-influx (R 
0.32 ± 0.26).
In the next experiment four or five repeated treatments of
capsaicin on the same cultured sensory neurons were performed,
and the effect of 500 nM HK-1 and SP was investigated on
capsaicin-evoked Ca2+-influx. The first application of 330 nM
capsaicin induced transient Ca2+-accumulation which gradually
decreased in response to the second capsaicin stimulus due to
TRPV1 (transient receptor potential cation channel subfamily V
member 1) desensitization. Meanwhile, both HK-1 and SP
administered in separate cultures after the second capsaicin
stimulus diminished the desensitization as shown by the third
and fourth capsaicin-evoked responses (Figures 6F–I).
DISCUSSION
Here we provide the first evidence for an important role of HK-1
in pain transmission using different arthritis models. This is likely
to be mediated by direct activation of primary sensory neurons
via NK1R-independent, PTX-insensitive, but extracellular Ca2+-
dependent mechanism. Besides its key importance in pain
development, HK-1 has a complex regulatory function in joint
inflammatory processes: it mediates edema formation and
histopathological alterations including inflammatory cell
accumulation, but inhibits early neutrophil/macrophage-
dependent MPO-activity increase in the chronic model.
K/BxN induced arthritis is a widely accepted chronic passive
transfer disease model (Malcangio, 2020), MCT is an important
FIGURE 3 | Representative histopathological pictures of safranin O-stained tibiotarsal joint showing ×100 and ×200 magnifications with 500 and 200 µm scale
bars, respectively. ti  tibia, ta  tarsus, s  synovium (A). Semiquantitative histopathological score of K/BxN serum treated wild type (WT) and hemokinin-deficient
(Tac4−/−) arthritic mice in comparison with non-arthritic controls. Box plots demonstrate the medians with upper and lower quartiles of n  three to five per group (*p <
0.05 vs. WT, Mann-Whitney test) (B).
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local mediator of inflammation (Kobayashi and Okunishi, 2002),
mediating its effects through sensory neurons (Borbély et al.,
2016), and acute CFA (Billiau and Matthys, 2001) induced
arthritis is initiated by macrophages. Using these three
methods we could obtain a more detailed picture on how HK-
1 influences the development of joint inflammation and
related pain.
The deficiency of HK-1, but not the NK1R resulted in
significantly decreased swelling in the acute models and also in
the early phase of the chronic experiment. Plasma leakage was not
altered by HK-1 on days 2 and 6, but only venular fenestration and
dye extravasation at the timepoints of the examination can be
detected with the applied in vivo fluorescent imaging technique
(Botz et al., 2015). This is one component of the edema formation,
but it does not exclusively explain paw swelling differences at the
respective observation timepoints mainly due to different kinetics
of the different components of the vascular changes (vasodilation
and leakage). We found no difference in edema formation in the
chronic adjuvant-induced active immunization-based model in
HK-1 or NK1R deficient mice (Borbély et al., 2013), therefore,
the edemogenic action of HK-1 seems to develop in a much earlier
phase of the inflammatory process. The arteriolar vasodilation and
microcirculation-increase was not affected either by HK-1-deletion
in theMCT-model, which suggests that HK-1 is not a predominant
regulator of the vascular (Borbély et al., 2013) functions.
Cellular inflammatory response in the chronic arthritis model,
as shown by the histopathological arthritis score, was significantly
reduced in HK-1-deficient mice. These results are supported by
the well-established immunoregulatory role of HK-1. B-cells play
an important role in RA, restricting their function has been
shown to ameliorate autoimmune arthritis (Tóth et al., 2019),
and HK-1 plays a critical role in the development of these cells
(Zhang et al., 2000). It also influences monocyte/macrophage
development (Berger et al., 2007) and neutrophils in vitro
(Klassert et al., 2008), which play a role in arthritis
development (Smith and Haynes, 2002). We found that
despite reduced functional and morphological inflammatory
alterations, MPO increase related to neutrophil and
macrophage activation occurred earlier (on day 2) in the
absence of HK-1. This virtual contradiction can be explained
by data showing that although MPO is generally known as a
mediator of tissue damage and inflammation, it has been shown
to prevent inflammation as well (Arnhold and Flemmig, 2010).
The elevation of MPO especially in the early phase of the
inflammatory cascade is considered to be protective, though
the mechanism is not well understood. MPO products have
been suggested to downregulate innate immunity, facilitate the
switch to adaptive immunity and inhibit T-cell reponses
(Prokopowicz et al., 2012). We have seen similar relation
between elevated MPO and decreased inflammatory
parameters in a previous study (Horváth et al., 2016). Since
HK-1 and MPO are both produced by neutrophils, they might
have direct interactions, but these have not yet been studied.
There is limited evidence about the involvement of HK-1 in pain
which, in agreement with our present results, found it to be pro-
nociceptive. Intracerebroventricular administration of low dose
(1–10 pmol) HK-1 caused nocifensive behavior, while high dose
(≥0.1 nmol) caused analgesia, all of which could be counteracted
by an NK1R antagonist, as well as opioid antagonists (Fu et al.,
2005). Other studies have shown that lumbar intrathecal
administration of 0.1 nmol HK-1 caused pain reaction in mice
which could be inhibited by an NMDA receptor antagonist
(Watanabe et al., 2016), but not an NK1R antagonist
(Watanabe et al., 2010). These results suggest that high doses
of HK-1 might have non-specific actions resulting in divergent
outcomes. Our earlier paper provided evidence that HK-1 has an
important role in neuropathic pain and microglia activation
(Hunyady et al., 2019). Other studies found that HK-1 mRNA
expression increases in the dorsal spinal cord of neuropathic rats
which could be blocked by inhibiting microglia activation and
FIGURE 4 | Changes in mechanonociceptive threshold (A), knee
diameter (B) and blood flow (C) in mast cell tryptase-induced acute arthritis of
wild type (WT) and hemokinin-1-deficient (Tac4−/−) mice. Data points
demonstrate the means ± SEM of n  5–10 per group; *p < 0.05, **p <
0.01, ***p < 0.001 vs. WT (repeated measures two-way ANOVA +
Bonferroni’s post test).
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alleviating pain (Matsumura et al., 2008). Our current results show
that HK-1 mediates both the early inflammatory pain, and the late
neuropathic-type pain in arthritis observed during the 3rd week of
the K/BxN experiment (Christianson et al., 2010), while other
studies showed the activation of spinal microglia in experimental
arthritis (Agalave et al., 2014). Earlier findings showed significantly
decreased HK-1 mRNA in the DRG in the collagen antibody
induced arthritis (CAIA) mouse model (Makino et al., 2012),
which is in agreement with the tendency we demonstrated in
the present paper, although the decrease was not statistically
significant due to individual variations. Joint inflammation was
alleviated by NK1R antagonists in the CAIA model, while the pain
could only be inhibited by indomethacin. In agreement with these
findings we have also showed that theNK1 receptor does not play a
role in arthritic pain, however, we conclude that HK-1 might be an
important mediator in an NK1R-independent manner by directly
activating primary sensory neurons.
Despite little information about HK-1 in pain and arthritis, the
best-known member of the tachykinin family, SP, and the NK1R
have been thoroughly investigated in these conditions
(Zieglgänsberger, 2019). It is well established that SP via NK1R
activation is involved in pain, which initiated considerable
pharmacological research in this field. Despite the proof-of-
concept of SP as a pain mediator, unfortunately, NK1R-
antagonists have failed as analgesics in clinical trials (Botz et al.,
2017), suggesting a yet unknown mechanism that can circumvent
NK1R-targeted approaches. SPmediates chondrocyte differentiation
in cell cultures (Millward-Sadler et al., 2003) and vasodilation in
arthritic mice (Keeble et al., 2005) through the NK1 receptor. SP-like
immunoreactivity was shown to increase in the primary sensory
neurons of dorsal root ganglia (DRG) of arthritic mice (Willcockson
et al., 2010), but the number of sensory nerve fibers of the arthritic
joint capsule, that are the main sources of SP, decreased (Buma et al.,
2000). Since SP andHK-1 cannot be differentiated by immunological
methods, it is possible that these immunohistochemistry data
referred (at least partially) to HK-1 expression.
In order to explore the direct effect and mechanism of action of
HK-1, we did further studies on cultured primary sensory neurons.
HK-1, but not SP, induced Ca2+-influx into these neurons. HK-1-
induced direct Ca2+-influx could be seen during PTX administration
and also in sensory neurons derived from NK1R−/− animals. The
main finding of our experiments was that the Ca2+-influx was
coming from the extracellular space in an NK1R-independent
manner since the signal disappeared in Ca2+-free extracellular
solution. It suggests an ion channel-coupled receptorial
mechanism, but not TRPV1- or TRPA1-mediated mechanism,
since the TRPV1 receptor antagonist AMG9810 and the TRPA1
receptor antagonist HC 030031 did not influence the HK-1-induced
Ca2+ influx response. Furthermore, even lower concentrations of
both HK-1 (similarly to SP) diminished desensitization of the
TRPV1 receptor that upon repeated capsaicin administration
could also contribute to the peripheral pain generating and
maintaining effect of HK-1. The neuronal activating potential of
HK-1 is supported by earlier data showing the ability of HK-1 to
evoke direct post-synaptic activation of cholinergic hippocampal
neurons in a tetrodotoxin-resistant manner. However, unlike
sensory neurons, this response was not inhibited in Ca2+-fee
media and was similar to the effect of SP (Morozova et al., 2008).
FIGURE 5 | Changes in mechanonociceptive threshold (A), AP knee diameter (B), and MPO-activity (C) in CFA-induced acute arthritis of WT and HK-1-deficient
(Tac4−/−) mice. Data points demonstrate the means ± SEM (A), (B) or medians with upper and lower quartiles of n  8–15 per group; *p < 0.05, **p < 0.01, ***p < 0.001
vs. WT, ###p < 0.001 vs. control (repeated measures two-way ANOVA + Bonferroni’s post test; for MPO activity: one-way ANOVA + Bonferroni’s post test).
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FIGURE 6 | Effect of HK-1 and SP in cultured primary sensory neurons. Change in the fluorescence ratio (R  F340/F380) in HK-1-sensitive cells (•) is presented.
C: HK-1 and PTX co-administration,◆: fluorescence signal in neurons from NK1R−/− animals, ○: HK-1 and CP99994 NK1 receptor antagonist administration, □: HK-1
and AMG9810 TRPV1 receptor antagonist, ■: HK-1 and HC 030031 TRPA1 receptor antagonist. No signal was detected in Ca2+-free extracellular solution. N  19–49
cells/group (A). The percentage of responsive cells to HK-1, HK-1+PTX, HK-1 in Ca2+-free condition, HK-1+NK1 receptor antagonist CP99994 and HK-1 in TG
from NK1R−/− animals, HK-1 + TRPV1 receptor antagonist AMG9810 and HK-1 + TRPA1 receptor antagonist HC 030031 is presented. Ca2+-responses are presented
in % of total number of examined neurons. N  19–49 cells per group (B). Original Ca2+-imaging registrations after HK-1 administration. Increases of R  340/380
fluorescence in fura-2 loaded cultured TG neurons (C). Original Ca2+-imaging registrations after HK-1 administration in TG neurons from NK1 gene deficient mice (D).
Original Ca2+-imaging registrations after HK-1 administration in Ca2+-free solution (E). Effect of HK-1 on capsaicin-induced Ca2+-influx. Increases of R  340/380
fluorescence in fura-2 loaded neurons are presented, **p < 0.01, NS (vs. caps1, one-way ANOVA with Bonferroni’s multiple comparison post hoc test, n  16) (F). Effect
of HK-1 on capsaicin-induced Ca2+-influx. Original Ca2+-imaging registrations after capsaicin and HK-1 administration (G). Effect of SP on capsaicin-induced Ca2+-
influx. Increases of R  340/380 fluorescence in fura-2 loaded neurons are presented, ***p < 0.001, NS (vs. caps1, one-way ANOVA with Bonferroni’s multiple
comparison post hoc test, n  17) (H). Effect of SP on capsaicin-induced Ca2+-influx. Original Ca2+-imaging registrations after capsaicin and SP administration (I).
Frontiers in Pharmacology | www.frontiersin.org January 2021 | Volume 11 | Article 59447910
Borbély et al. Hemokinin-1 in Arthritis
Some limitations of the present study are that we only performed
our experiments onmale mice to avoid the influencing factors of the
estrus cycle and that we could detect HK-1 neither qualitatively by
immunohistochemistry nor quantitatively by immune assays due to
the lack of antibodies able to differentiate it from SP.
In conclusion, we provide the first evidence using three
different mouse models mimicking distinct mechanisms of
rheumatoid arthritis and integrative methodology (functional,
in vivo optical imaging, cell cultures) that HK-1 mediates several
arthritic inflammatory mechanisms and pain by direct activation
of primary sensory neurons not via its classical NK1 receptor. The
main translational value is that we modeled the late neuropathic
component of arthritic pain related to neuropathic mechanisms
without inflammatory symptoms and describe the involvement of
HK-1 in this process. These findings add to the growing evidence
that HK-1 has another, so far unidentified target initiating further
research in this direction.
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GLOSSARY
AITC allyl isothiocyanate
CAIA collagen antibody induced arthritis
CFA complete Freund’s adjuvant
DMARD disease-modifying antirheumatic drugs
D-MEM Dulbecco’s-Modified Eagle Medium-low glucose
DMSO dimethyl sulfoxide
DPE dynamic plantar esthesiometer







MCT mast cell tryptase
MPO Myeloperoxidase
NGF nerve growth factor
NK1R tachykinin neurokinin-1 receptor
NK2R tachykinin neurokinin-2 receptor
NK3R tachykinin neurokinin-3 receptor
NMDA N-metil-d-aspartic acid
NSAID nonsteroidal anti-inflammatory drugs
PAR2 protease-activated receptor two
PBS phosphate-buffered saline
PCR Polymerase chain reaction
PTX pertussis toxin
RA rheumatoid arthritis
ROI region of interest
SP substance P
Tac4 preprotachykinin-4 gene
Tacr1 tachykinin receptor one gene, encodes NK1R
TG trigeminal ganglion
TRPA1 transient receptor potential cation channel subfamily A member one
TRPV1 transient receptor potential cation channel subfamily V
member one
WT wild type
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